HAMP and beta thalassemia: Furthermore, ERFE suppresses the transcription of hepcidin in hepatocytes, resulting in increased iron availability in conditions characterized by greater iron request [28], such as pregnancy [29] and in patients with beta-thalassemia and iron-deficiency anemia [30].